Convergen Raises $10 Million to Propel TrimTAC Platform for Neurodegenerative Disease Solutions Convergen has closed a $10 million seed funding round to enhance its TrimTAC platform aimed at treating neurodegenerative disorders. The funding will help tackle critical challenges in targeted protein degradation.

Convergen Raises $10 Million to Propel TrimTAC Platform for Neurodegenerative Disease Solutions #China #Suzhou #Convergen #TrimTAC #TRIM21

NuitDebout33: #Bordeaux Retour sur le rassemblement contre l'homophobie du 22/06 en vidéo#NuitDebout33 #Convergen…

dailymotion.com/video/xeylz7_l…

Thanks to Google, TV Ads Are About to Start Watching You Google will soon give advertisers the power to target TV ...

Google can now draw lines that no one else can, TVC to ecomm. Next, in store w/ @googlewallet. #thisisbig #convergen… http://bit.ly/1GS9fWL